1. ScholarBank@NUS

Eng Huat Tan

rp08628

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Eng Huat Tan
Variants
Tan, E.-H.
Tan, E.H.
 
Main Affiliation
 
Faculty
 
Email
gmsteh@nus.edu.sg
 

Publications

Refined By:
Subject:  Science & Technology
Subject:  Life Sciences & Biomedicine

Results 1-7 of 7 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
1Dec-2022A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCLai, Gillianne GY ; Yeo, Jia Chi; Jain, Amit ; Zhou, Siqin ; Pang, Mengyuan; Alvarez, Jacob JS; Sim, Ngak Leng; Tan, Aaron C ; Suteja, Lisda; Lim, Tze Wei; Guo, Yu Amanda; Shen, Meixin; Saw, Stephanie PL ; Rohatgi, Neha; Yeong, Joe PS; Takano, Angela ; Lim, Kiat Hon ; Gogna, Apoorva ; Too, Chow Wei ; Da Zhuang, Kun ; Tan, Wan Ling ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Wang, Lanying; Toh, Chee Keong ; Lim, Wan-Teck ; Tam, Wai Leong ; Tan, Sze Huey ; Skanderup, Anders MJ ; Tan, Eng-Huat ; Tan, Daniel SW 
214-Aug-2023Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer (vol 17, 66, 2023)Lee, Ning-Yuan; Hum, Melissa ; Zihara, Sabna; Wang, Lanying; Myint, Matthew K ; Lim, Darren Wan-Teck ; Toh, Chee-Keong ; Skanderup, Anders; Samol, Jens; Tan, Min-Han ; Ang, Peter; Lee, Soo-Chin ; Tan, Eng-Huat ; Lai, Gillianne GY ; Tan, Daniel SW ; Yap, Yoon-Sim ; Lee, Ann SG 
33-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
424-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
517-Jul-2023Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerLee, Ning-Yuan; Hum, Melissa ; Zihara, Sabna; Wang, Lanying; Myint, Matthew K ; Lim, Darren Wan-Teck ; Toh, Chee-Keong ; Skanderup, Anders ; Samol, Jens; Tan, Min-Han ; Ang, Peter; Lee, Soo-Chin ; Tan, Eng-Huat ; Lai, Gillianne GY ; Tan, Daniel SW ; Yap, Yoon-Sim ; Lee, Ann SG 
61-Jun-2018Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCTan, Eng-Huat ; Lim, Wan-Teck ; Ahn, Myung-Ju; Ng, Quan-Sing ; Ahn, Jin Seok; Tan, Daniel Shao-Weng ; Sun, Jong-Mu; Han, May; Payumo, Francis C; Mckee, Krista; Yin, Wei; Credi, Marc; Agarwal, Shefali; Jac, Jaroslaw; Park, Keunchil
7Apr-2023Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistanceMa, Jun ; Tan, Sze Huey ; Yin, Daniel Xing Cheng; Tran, Nguyen Tuan Anh ; San Tan, Gek ; Lai, Gillianne Geet Yi ; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Rajasekaran, Tanujaa ; Tan, Eng-Huat ; Lim, Tony Kiat Hon ; Tan, Daniel Shao-Weng ; Lim, Darren Wan-Teck ; Ng, Quan Sing ; Tan, Wan Ling